purpos
determin
infecti
caus
patient
uveiti
unknown
origin
intraocular
fluid
analysi
design
casecontrol
studi
origin
infect
thought
caus
approxim
case
associ
noninfecti
system
diseas
although
patient
manag
efficaci
treatment
differenti
diagnosi
crucial
half
uveiti
patient
underli
caus
remain
unknown
pathogen
commonli
associ
infecti
uveiti
immunocompet
patient
toxoplasma
gondii
herp
simplex
viru
hsv
varicellazost
viru
vzv
recent
year
infecti
agent
implic
etiolog
uveiti
notabl
rubella
viru
cytomegaloviru
cmv
cmv
current
recogn
common
caus
uveiti
immunocompromis
patient
studi
perform
extens
search
infecti
agent
caus
uveiti
far
escap
attent
aqueou
humor
sampl
uveiti
patient
analyz
retrospect
laboratori
avail
realtim
polymeras
chain
reaction
pcr
assay
varieti
virus
bacteria
includ
pathogen
previous
associ
uveiti
enterovirus
epsteinbarr
virus
ebv
human
herpesviru
influenza
viru
rubella
viru
mycoplasma
pneumonia
caus
conjunct
andor
kerat
enceph
adenovirus
coronavirus
enterovirus
influenza
viru
parainfluenzavirus
human
parechoviru
hpev
respiratori
syncyti
viru
chlamydia
pneumonia
chlamydia
trachomati
find
suggest
human
parechoviru
may
involv
pathogenesi
infecti
kerato
uveiti
patient
sampl
ocular
fluid
sampl
analyz
studi
uveiti
patient
visit
ophthalmolog
clinic
univers
medic
center
utrecht
octob
june
suspect
infecti
uveiti
patient
classifi
use
uveiti
nomenclatur
accord
recommend
standard
uveiti
nomenclatur
work
group
patient
undergon
uveiti
screen
consist
erythrocyt
sediment
rate
red
white
blood
cell
count
determin
serum
angiotensinconvert
enzym
level
serolog
test
syphili
chest
radiographi
select
patient
also
underw
serolog
test
borrelia
burgdorferi
patient
aqueou
sampl
perform
diagnost
purpos
sampl
store
within
hour
collect
process
laboratori
analysi
initi
analysi
perform
hsv
vzv
case
posterior
uveiti
also
toxoplasma
cmv
pcr
goldmannwitm
coeffici
gwc
determin
intraocular
antibodi
product
patient
neg
mention
agent
suffici
amount
ocular
fluid
remain
studi
case
fortynin
patient
anterior
uveiti
au
posterior
uveiti
pu
panuv
tabl
au
patient
immunocompromis
result
immunosuppress
medic
lethal
midlin
granuloma
allogen
stem
cell
transplant
hematolog
malign
patient
pu
panuv
immunocompromis
acquir
immunodefici
syndrom
receiv
immunosuppress
drug
tabl
remaind
ocular
fluid
sampl
patient
pcrandor
gwcconfirm
infecti
uveiti
ocular
toxoplasmosi
n
hsv
anterior
uveiti
n
rubella
virusassoci
fuch
heterochrom
uveiti
syndrom
fhu
n
patient
cataract
absenc
intraocular
inflamm
n
serv
control
nucleic
acid
isol
realtim
pcr
ocular
fluid
sampl
analyz
presenc
adenoviru
ebv
mycoplasma
pneumonia
chlamydia
pneumonia
chlamydia
trachomati
dna
coronavirus
enterovirus
human
metapneumoviru
influenza
b
viru
parainfluenza
viru
hpev
respiratori
syncyti
viru
b
rubella
viru
rna
done
previous
sampl
patient
anterior
uveiti
also
analyz
cmv
toxoplasma
dna
rna
extract
l
ocular
fluid
use
magna
pure
lc
total
nucleic
acid
isol
kit
roch
mannheim
germani
monitor
qualiti
extract
subsequ
amplif
procedur
standard
dose
phocin
herpesviru
type
encephalomyocard
viru
ad
sampl
intern
control
prior
extract
nucleic
acid
collect
volum
l
detect
rna
virus
copydna
cdna
produc
mix
l
extract
nucleic
acid
l
revers
transcriptas
mix
taqman
revers
transcript
reagent
appli
biosystem
foster
citi
california
usa
incub
mixtur
minut
minut
cdna
synthesi
reaction
stop
incub
minut
per
amplif
reaction
l
extract
nucleic
acid
dna
detect
l
cdna
rna
detect
use
realtim
pcr
assay
perform
abi
prism
sequenc
detect
system
appli
biosystem
branchburg
new
jersey
usa
chlamydia
trachomati
l
extract
nucleic
acid
analyz
use
coba
amplicor
chlamydia
trachomati
detect
kit
accord
instruct
manufactur
roch
sampl
examin
case
posit
outcom
realtim
pcr
reaction
repeat
two
human
parechovirusposit
sampl
confirm
nucleic
acid
sequenc
sampl
intern
control
inhibit
exclud
primer
probe
use
list
tabl
antibodi
detect
assay
intraocular
product
antibodi
rubella
viru
goldmannwitm
coeffici
assess
describ
previous
serum
intraocular
immunoglobulin
ig
g
titer
determin
use
biotrin
intern
human
herp
viru
igg
immunofluoresc
assay
dublin
ireland
serum
intraocular
igg
ebv
determin
use
panbio
vca
igg
elisa
grenobl
franc
inhibit
patient
sampl
posit
pcr
reaction
found
epsteinbarr
viru
n
rubella
viru
n
human
herpesviru
n
human
parechoviru
n
pcr
reaction
pathogen
neg
control
sampl
neg
except
toxoplasma
chorioretin
control
sampl
posit
ebv
sampl
posit
rubella
viru
intraocular
antibodi
product
also
test
pcrposit
rubella
viru
rna
patient
uveiti
unknown
caus
posit
pcr
result
rubella
viru
human
parechoviru
describ
rubella
viru
case
femal
patient
complain
gradual
decreas
visual
acuiti
right
eye
od
medic
histori
includ
pneumothorax
bilater
pneumonia
mani
year
ago
sign
system
diseas
visual
acuiti
od
anterior
chamber
vitreou
od
reveal
cell
synechia
subcapsular
posterior
cataract
fine
kerat
precipit
kp
vitreou
opac
retina
normal
left
eye
os
full
visual
acuiti
abnorm
examin
uveiti
screen
result
within
normal
limit
clinic
diagnosi
fuch
heterochrom
uveiti
syndrom
made
cataract
extract
implant
intraocular
len
perform
well
par
plana
vitrectomi
vitreou
opac
examin
vitreou
evid
system
andor
intraocular
infect
use
pcr
gwc
cmv
hsv
vzv
toxoplasma
borrelia
burgdorferi
bartonella
hensela
microbiolog
cultur
neg
cytolog
examin
reveal
malign
cell
pcr
rubella
viru
detect
vitreou
fluid
subsequ
antibodi
analysi
rubella
viru
reveal
presenc
intraocular
igg
gwc
neg
ratio
howev
comparison
hsv
vzv
cmv
en
toxoplasma
intraocular
antibodi
product
rubella
viru
elev
human
case
man
refer
decreas
visual
acuiti
od
floater
sinc
month
prior
medic
histori
contributori
patient
use
medic
uveiti
screen
result
within
normal
rang
remark
heterochromia
eye
present
sinc
childhood
serolog
evid
activ
infect
cmv
hsv
vzv
toxoplasma
treponema
pallidum
borrelia
burgdorferi
serum
igg
immunoblot
posit
howev
distinct
past
ongo
infect
could
made
ocular
examin
visual
acuiti
od
cornea
reveal
presenc
kerat
precipit
anterior
chamber
clear
synechia
sever
small
noduli
present
pupillari
edg
iri
cataract
observ
funduscopi
od
reveal
vitreou
cell
sever
peripher
snowbal
fundoscop
find
normal
os
full
visual
acuiti
howev
peripher
vitreou
opac
observ
possibl
previou
infect
borrelia
patient
treat
intraven
ceftriaxon
addit
periocular
steroid
effect
diagnost
vitrectomi
perform
cytolog
microbiolog
examin
reveal
caus
uveiti
vitreou
analysi
neg
cmv
hsv
vzv
borrelia
pcr
gwc
rubella
viru
gwc
neg
ratio
although
intraocular
igg
detect
gwc
elev
comparison
cmv
hsv
vzv
therefor
rubella
virusassoci
fhu
could
exclud
three
month
vitrectomi
patient
regain
full
visual
acuiti
although
kerat
precipit
od
remain
retrospect
vitreou
fluid
appear
posit
pcr
immunofluoresc
assay
demonstr
patient
seroposit
human
parechoviru
case
male
patient
refer
center
anterior
uveiti
year
durat
pseudophak
os
twentynin
year
prior
patient
underw
cataract
extract
implant
irisclip
len
os
previou
trauma
ocular
examin
visual
acuiti
os
hand
movement
tabl
central
corneal
scar
seen
cell
present
anterior
chamber
vitreou
clear
funduscopi
reveal
abnorm
od
full
visual
acuiti
abnorm
eye
normal
intraocular
pressur
patient
system
complaint
use
medic
uveiti
screen
result
within
normal
limit
patient
also
diagnos
neurosyphili
uveiti
clinic
attribut
irrit
caus
irisclip
len
therefor
surgic
remov
vitreou
sampl
obtain
surgeri
analysi
ocular
fluid
neg
hsv
vzv
pcr
gwc
cmv
toxoplasma
pcr
retrospect
posit
human
parechoviru
pcr
ocular
examin
month
remov
intraocular
len
reveal
quiet
os
case
male
refer
persist
kerat
os
thought
caus
hsv
patient
respond
system
topic
treatment
acyclovir
valacyclovir
previou
medic
ophthalm
histori
unremark
uveiti
screen
reveal
abnorm
ocular
examin
visual
acuiti
os
infiltr
upper
part
cornea
epitheli
defect
sporad
cell
anterior
chamber
observ
tabl
corneal
sensit
normal
vitreou
clear
retin
find
unremark
intraocular
pressur
normal
od
full
visual
acuiti
abnorm
aqueou
analysi
neg
hsv
vzv
toxoplasma
pcr
gwc
cmv
pcr
howev
retrospect
pcr
posit
human
parechoviru
patient
treat
antibiot
eye
ointment
corneal
lesion
anterior
uveiti
slowli
becam
quiet
femal
patient
ophthalmolog
histori
cataract
extract
eye
age
refer
institut
secondari
glaucoma
od
patient
system
complaint
use
medic
od
reveal
pupillari
seclus
intraocular
pressur
iop
mm
hg
examin
corneal
edema
kerat
precipit
note
od
tabl
iri
reveal
atroph
area
fluorescein
angiographi
reveal
slight
optic
disc
leakag
cystoid
macular
edema
od
iop
initi
normal
laser
iridotomi
local
treatment
howev
intermitt
period
iop
elev
mm
hg
regularli
encount
trabeculectomi
requir
presum
diagnosi
includ
lowgrad
propionibacterium
endophthalm
variou
caus
hypertens
uveiti
tabl
screen
examin
within
normal
limit
well
serolog
borrelia
bartonella
aqueou
sampl
perform
pcr
neg
hsv
vzv
cmv
toxoplasma
gwc
neg
hsv
vzv
cultur
neg
propionibacterium
retrospect
patient
found
posit
human
parechoviru
pcr
case
male
patient
refer
panuv
focal
chorioretin
lesion
os
sinc
month
prior
time
visual
acuiti
os
decreas
finger
count
examin
kp
cell
anterior
chamber
vitreou
note
activ
lesion
locat
peripheri
retina
tabl
ebv
caus
agent
infecti
mononucleosi
sever
malign
implic
possibl
caus
uveiti
primari
ocular
nonhodgkin
lymphoma
central
nervou
system
studi
ebv
detect
ocular
fluid
patient
anterior
uveiti
unknown
caus
patient
toxoplasma
chorioretin
igg
analysi
patient
show
evid
intraocular
antibodi
product
ebv
presenc
ebv
genom
eye
patient
variou
caus
uveiti
demonstr
previous
found
independ
clinic
diagnosi
clinic
signific
phenomenon
yet
establish
moreov
studi
ongkosuwito
associ
found
ebv
also
ocular
fluid
patient
laboratoryconfirm
toxoplasmosi
ocular
fluid
patient
without
ocular
inflamm
intraocular
antibodi
product
analysi
requir
determin
whether
ebv
true
caus
intraocular
inflamm
one
patient
pcrposit
rubella
viru
caus
agent
german
measl
congenit
rubella
syndrom
rubella
viru
associ
fhu
fhuslik
uveiti
patient
clinic
diagnos
incomplet
fhu
iri
heterochromia
atrophi
betaherpesviru
caus
agent
roseola
infantum
exanthema
subitum
childhood
diseas
addit
recogn
import
opportunist
infect
follow
bone
marrow
andor
stem
cell
transplant
pcrposit
patient
case
neither
child
immunosuppress
antibodi
analysi
ocular
fluid
immunofluoresc
assay
reveal
presenc
intraocular
igg
howev
absenc
intraocular
antibodi
product
necessarili
exclud
intraocular
infect
previous
report
simultan
use
pcr
gwc
immunocompet
patient
diagnosi
pcr
establish
case
moreov
de
boer
associ
found
patient
presum
herpet
anterior
uveiti
pcr
frequent
posit
gwc
implic
ocular
inflamm
notabl
posterior
part
eye
affect
patient
anterior
uveiti
heterochromia
present
sinc
childhood
heterochromia
classic
associ
fhu
develop
viral
infect
hsv
vzv
detect
eye
might
clinic
relev
find
howev
like
herp
virus
resid
latent
cell
lymphoid
myeloid
lineag
may
enter
inflam
eye
via
immun
cell
similar
hiv
possibl
ebv
role
caus
anterior
uveiti
inconclus
studi
requir
human
parechovirus
belong
genu
parechoviru
within
famili
picornavirida
may
caus
gastroenter
enceph
flaccid
paralysi
young
children
rare
adult
ocular
diseas
attribut
picornaviru
infect
particularli
enterovirus
echovirus
coxsackievirus
publish
associ
parechovirus
ocular
diseas
report
yet
studi
ocular
fluid
patient
undiagnos
unilater
uveiti
pcrposit
hpev
unfortun
intraocular
antibodi
product
could
establish
appropri
serolog
assay
avail
enough
ocular
fluid
left
perform
viral
cultur
one
patient
case
intraocular
hpev
immunocompromis
tabl
diagnos
activ
syphili
indic
neurosyphili
ocular
syphili
howev
upon
treatment
penicillin
ocular
condit
improv
patient
hivposit
multipl
uveiti
entiti
may
contribut
ocular
diseas
patient
unilater
anterior
uveiti
corneal
involv
cell
anterior
chamber
suggest
ocular
viral
infect
tabl
research
requir
determin
hpev
play
role
pathogenesi
infecti
anterior
uveiti
surpris
find
viru
associ
diseas
children
eye
adult
howev
infect
childhood
known
caus
intraocular
diseas
adult
case
rubella
viru
vast
major
ocular
fluid
sampl
neg
pcr
analysi
multipl
virus
bacteria
sever
explan
result
first
uveiti
might
noninfecti
origin
second
number
dna
rna
copi
present
ocular
sampl
may
detect
level
may
attribut
low
amount
input
nucleic
acid
inher
diagnost
assay
intraocular
fluid
altern
time
sampl
may
caus
agent
alreadi
clear
eye
case
diagnost
approach
may
use
detect
intraocular
antibodi
product
goldmannwitm
coeffici
calcul
known
also
system
neurolog
viral
infect
pcr
assay
sensit
earli
infect
wherea
antibodi
detect
much
longer
period
time
thu
provid
wider
window
detect
final
may
pathogen
cover
assay
involv
case
studi
address
multipl
infecti
caus
patient
undiagnos
uveiti
reveal
possibl
new
caus
infecti
uveiti
investig
requir
narrow
diagnost
gap
patient
presum
infecti
uveiti
